Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Molecular pathogenesis of keratocystic odontogenic tumors developing in nevoid basal cell carcinoma syndrome.

Suzuki M, Nagao K, Hatsuse H, Sasaki R, Saito K, Fujii K, Miyashita T.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Sep;116(3):348-53. doi: 10.1016/j.oooo.2013.06.017.

PMID:
23953420
2.

PTCH1 and SMO gene alterations in keratocystic odontogenic tumors.

Sun LS, Li XF, Li TJ.

J Dent Res. 2008 Jun;87(6):575-9.

PMID:
18502968
3.

Novel PTCH1 mutations in patients with keratocystic odontogenic tumors screened for nevoid basal cell carcinoma (NBCC) syndrome.

Pastorino L, Pollio A, Pellacani G, Guarneri C, Ghiorzo P, Longo C, Bruno W, Giusti F, Bassoli S, Bianchi-ScarrĂ  G, Ruini C, Seidenari S, Tomasi A, Ponti G.

PLoS One. 2012;7(8):e43827. doi: 10.1371/journal.pone.0043827. Epub 2012 Aug 27.

4.

Mechanisms of inactivation of PTCH1 gene in nevoid basal cell carcinoma syndrome: modification of the two-hit hypothesis.

Pan S, Dong Q, Sun LS, Li TJ.

Clin Cancer Res. 2010 Jan 15;16(2):442-50. doi: 10.1158/1078-0432.CCR-09-2574. Epub 2010 Jan 12.

5.

PTCH1 gene mutations in Keratocystic odontogenic tumors: a study of 43 Chinese patients and a systematic review.

Guo YY, Zhang JY, Li XF, Luo HY, Chen F, Li TJ.

PLoS One. 2013 Oct 21;8(10):e77305. doi: 10.1371/journal.pone.0077305. eCollection 2013. Review.

6.

[PTCH2 gene alterations in keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome].

Xu LL, Li TJ.

Beijing Da Xue Xue Bao Yi Xue Ban. 2008 Feb 18;40(1):15-8. Chinese.

7.

Multiple keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome having distinct PTCH1 mutations: a case report.

Sasaki R, Miyashita T, Matsumoto N, Fujii K, Saito K, Ando T.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Aug;110(2):e41-6. doi: 10.1016/j.tripleo.2010.04.006.

PMID:
20659694
8.

Underestimated PTCH1 mutation rate in sporadic keratocystic odontogenic tumors.

Qu J, Yu F, Hong Y, Guo Y, Sun L, Li X, Zhang J, Zhang H, Shi R, Chen F, Li T.

Oral Oncol. 2015 Jan;51(1):40-5. doi: 10.1016/j.oraloncology.2014.09.016. Epub 2014 Nov 18.

PMID:
25458233
9.

Clinical manifestations and treatment for keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome: a study in 25 Japanese patients.

Shimada Y, Morita K, Kabasawa Y, Taguchi T, Omura K.

J Oral Pathol Med. 2013 Mar;42(3):275-80. doi: 10.1111/j.1600-0714.2012.01202.x. Epub 2012 Aug 8.

PMID:
22882291
10.

PTCH germline mutations in Chinese nevoid basal cell carcinoma syndrome patients.

Li TJ, Yuan JW, Gu XM, Sun LS, Zhao HS.

Oral Dis. 2008 Mar;14(2):174-9. doi: 10.1111/j.1601-0825.2007.01369.x.

PMID:
18302678
11.

Heterozygous PTCH1 Mutations Impact the Bone Metabolism in Patients With Nevoid Basal Cell Carcinoma Syndrome Likely by Regulating SPARC Expression.

Hong Y, Zhang J, Zhang H, Li X, Qu J, Zhai J, Zhang L, Chen F, Li T.

J Bone Miner Res. 2016 Jul;31(7):1413-28. doi: 10.1002/jbmr.2815. Epub 2016 Mar 12.

12.

Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation.

Kijima C, Miyashita T, Suzuki M, Oka H, Fujii K.

Fam Cancer. 2012 Dec;11(4):565-70. doi: 10.1007/s10689-012-9548-0.

PMID:
22829011
13.

The large intracellular loop of ptch1 mediates the non-canonical Hedgehog pathway through cyclin B1 in nevoid basal cell carcinoma syndrome.

Yu FY, Hong YY, Qu JF, Chen F, Li TJ.

Int J Mol Med. 2014 Aug;34(2):507-12. doi: 10.3892/ijmm.2014.1783. Epub 2014 May 16.

PMID:
24840883
14.

PTCH1 mutation and local aggressiveness of odontogenic keratocystic tumors in children: is there a relationship?

Kadlub N, Coudert A, Gatibelza ME, El Houmami N, Soufir N, Ruhin-Poncet B, L'hermine AC, Berdal A, Vazquez MP, Descroix V, Picard A.

Hum Pathol. 2013 Jun;44(6):1071-8. doi: 10.1016/j.humpath.2012.09.012. Epub 2013 Jan 11.

PMID:
23317547
15.

Analysis of the neoplastic nature and biological potential of sporadic and nevoid basal cell carcinoma syndrome-associated keratocystic odontogenic tumor.

Katase N, Nagatsuka H, Tsujigiwa H, Gunduz M, Tamamura R, Pwint HP, Rivera RS, Nakajima M, Naomoto Y, Nagai N.

J Oral Pathol Med. 2007 Oct;36(9):550-4.

PMID:
17850439
16.

Multiple nevoid basal cell carcinoma syndrome associated with congenital orbital teratoma, caused by a PTCH1 frameshift mutation.

Rodrigues AL, Carvalho A, Cabral R, Carneiro V, Gilardi P, Duarte CP, Puente-Prieto J, Santos P, Mota-Vieira L.

Genet Mol Res. 2014 Jul 25;13(3):5654-63. doi: 10.4238/2014.July.25.21.

17.

Genetic screening for nevoid basal cell carcinoma syndrome in patients with a solitary keratocystic odontogenic tumour is not useful.

Karagozoglu KH, Van Hagen JM, Baart JA, Van Der Waal I.

Minerva Stomatol. 2011 Jan-Feb;60(1-2):1-4.

PMID:
21252844
18.

[Studies on keratocystic odontogenic tumors].

Li TJ, Sun LS, Luo HY, Yuan JW, Gao L, Gu XM, Li XF, Xu LL.

Beijing Da Xue Xue Bao Yi Xue Ban. 2009 Feb 18;41(1):16-20. Chinese.

19.

Integrated genotypic analysis of hedgehog-related genes identifies subgroups of keratocystic odontogenic tumor with distinct clinicopathological features.

Shimada Y, Katsube K, Kabasawa Y, Morita K, Omura K, Yamaguchi A, Sakamoto K.

PLoS One. 2013 Aug 7;8(8):e70995. doi: 10.1371/journal.pone.0070995. eCollection 2013.

20.

Frameshift mutation in the PTCH2 gene can cause nevoid basal cell carcinoma syndrome.

Fujii K, Ohashi H, Suzuki M, Hatsuse H, Shiohama T, Uchikawa H, Miyashita T.

Fam Cancer. 2013 Dec;12(4):611-4. doi: 10.1007/s10689-013-9623-1.

PMID:
23479190

Supplemental Content

Support Center